Evidence map›Paper›PMID 30157821›Full record

SynthesisBMC surgery2018

A systematic review on the use of topical hemostats in trauma and emergency surgery.

Osvaldo Chiara, Stefania Cimbanassi, Giovanni Bellanova, Massimo Chiarugi, Andrea Mingoli, Giorgio Olivero, Sergio Ribaldi, Gregorio Tugnoli, Silvia Basilicò, Francesca Bindi and 13 more

Registry-linked trialOpen access · goldAbstract readSystematic Review
In one paragraph

Synthesis in BMC surgery, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04357483 (Randomized Controlled Study to Evaluate the Effect of Thrombin-containing Collagen-based Hemostatic Matrix on Prevention of Pancreatic Fistula After Pancreatecomy), which is not on this map. Cited by 66 papers.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed
8.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04357483 phase4unknown statusnot on this map

Randomized Controlled Study to Evaluate the Effect of Thrombin-containing Collagen-based Hemostatic Matrix on Prevention of Pancreatic Fistula After Pancreatecomy

TypeinterventionalSponsorAsan Medical CenterRan2018 to 2020Enrolled60ConditionsPancreatic TumorArmsflowable thrombin containing collagen hemostat matrix, thrombin coated L-dopa contained collagen patch
3 · Its place in the literature

Who cites it

66 citing papers in PubMed, 159 citations in OpenAlex.

  1. Trial
  2. Trial
  3. A Study of Safety and Effectiveness of Evicel Fibrin Sealant as an Adjunctive Hemostat in Pediatric Surgery.European journal of pediatric surgery : official journal of Austrian Association of Pediatric Surgery ... [et al] = Zeitschrift fur Kinderchirurgie · 2024
    Trial
  4. Safety and Hemostatic Effectiveness of SURGICEL® Powder in Mild and Moderate Intraoperative Bleeding.Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
    Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Should we consider styptics in patients with bleeding disorders?Research and practice in thrombosis and haemostasis · 2026
    Article
  12. Article
  13. Article
  14. Development of a 50% (w/v) aluminium chloride hexahydrate solution as haemostatic agent.European journal of hospital pharmacy : science and practice · 2025
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 13 institutions in 1 country.

Osvaldo ChiaraGeneral Surgery-Trauma Team, State University of Milano, Niguarda Hospital Milano, Piazza Benefattori dell'Ospedale, 3, 20162, Milan, Italy. ochiara@yahoo.com.
Stefania CimbanassiGeneral Surgery-Trauma Team, Niguarda Hospital, Milan, Italy.
Giovanni BellanovaGeneral Surgery, SS Annunziata Hospital, Taranto, Italy.
Massimo ChiarugiEmergency Surgery Unit, State University of Pisa, Cisanello Hospital, Pisa, Italy.
Andrea MingoliTrauma Surgery Unit-Department of Surgery-Emergency Surgery Department Policlinico Umberto I-Rome, Rome, Italy.
Giorgio OliveroDepartment of Surgical Sciences, State University of Torino, Turin, Italy.
Sergio RibaldiEmergency Surgery, Umberto I Hospital, Rome, Italy.
Gregorio TugnoliTrauma Surgery, Maggiore Hospital, Bologna, Italy.
Silvia BasilicòGeneral Surgery-Trauma Team, State University of Milano, Niguarda Hospital Milano, Piazza Benefattori dell'Ospedale, 3, 20162, Milan, Italy.
Francesca BindiGeneral Surgery-Trauma Team, State University of Milano, Niguarda Hospital Milano, Piazza Benefattori dell'Ospedale, 3, 20162, Milan, Italy.
Laura BrianiGeneral Surgery-Trauma Team, State University of Milano, Niguarda Hospital Milano, Piazza Benefattori dell'Ospedale, 3, 20162, Milan, Italy.
Federica RenziGeneral Surgery-Trauma Team, State University of Milano, Niguarda Hospital Milano, Piazza Benefattori dell'Ospedale, 3, 20162, Milan, Italy.
Piero ChirlettiGeneral Surgery and Pancreatic Surgery Unit, State University La Sapienza, Rome, Italy.
Giuseppe Di GreziaEmergency Surgery, Ladolfi Hospital, Avellino, Italy.
Antonio MartinoHonorable Chief- Emergency Surgery, Cardarelli Hospital, Naples, Italy.
Rinaldo MarzaioliDepartment of Emergency and Transplant Surgery, State University of Bari, Bari, Italy.
Giuseppe NoscheseTrauma Center, A.O.R.N Cardarelli, Naples, Italy.
Nazario PortolaniDepartment of Clinical and Experimental Sciences-State University of Brescia, Bari, Italy.
Paolo RuscelliDepartment of Emergency Surgery, Ospedali Riuniti, Ancona, Italy.
Mauro ZagoMinimally Invasive Surgery Unit- Policlinico S. Pietro, Ponte San Pietro, Bergamo, Italy.
Sebastian SgardelloGeneral Surgery-Trauma Team, State University of Milano, Niguarda Hospital Milano, Piazza Benefattori dell'Ospedale, 3, 20162, Milan, Italy.
Franco StagnittiState University of Rome "La Sapienza"-Polo Pontino, Latina, Italy.
Stefano MinielloDepartment of Surgery, University of Bari, Bari, Italy.
University of Milan · ITAzienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda · ITPoliclinico Umberto I · ITSapienza University of Rome · ITUniversity of Bari Aldo Moro · ITAzienda Ospedaliero Universitaria Ospedali Riuniti · ITFatebenefratelli Hospital · ITOspedale Antonio Cardarelli · ITOspedale Cisanello · ITOspedale San Pietro Fatebenefratelli · ITOspedale SS. Annunziata · ITUniversity of Brescia · ITUniversity of Turin · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundA wide variety of hemostats are available as adjunctive measures to improve hemostasis during surgical procedures if residual bleeding persists despite correct application of conventional methods for hemorrhage control. Some are considered active agents, since they contain fibrinogen and thrombin and actively participate at the end of the coagulation cascade to form a fibrin clot, whereas others to be effective require an intact coagulation system. The aim of this study is to provide an evidence-based approach to correctly select the available agents to help physicians to use the most appropriate hemostat according to the clinical setting, surgical problem and patient's coagulation status.

methodsThe literature from 2000 to 2016 was systematically screened according to PRISMA [Preferred Reporting Items for Systematic Reviews and Meta-Analyses] protocol. Sixty-six articles were reviewed by a panel of experts to assign grade of recommendation (GoR) and level of evidence (LoE) using the GRADE [Grading of Recommendations Assessment, Development and Evaluation] system, and a national meeting was held.

resultsFibrin adhesives, in liquid form (fibrin glues) or with stiff collagen fleece (fibrin patch) are effective in the presence of spontaneous or drug-induced coagulation disorders. Mechanical hemostats should be preferred in patients who have an intact coagulation system. Sealants are effective, irrespective of patient's coagulation status, to improve control of residual oozing. Hemostatic dressings represent a valuable option in case of external hemorrhage at junctional sites or when tourniquets are impractical or ineffective.

conclusionsLocal hemostatic agents are dissimilar products with different indications. A knowledge of the properties of each single agent should be in the armamentarium of acute care surgeons in order to select the appropriate product in different clinical conditions.

Indexed as

EmergenciesAdministration, TopicalHemorrhageHemostaticsHumansWounds and InjuriesHemostaticsEmergency surgeryFibrin adhesivesHemorrhageHemostatic dressingsHemostatsMechanical hemostatsSealantsSystematic reviewTrauma

Identifiers

PMID30157821
PMCPMC6116382
OpenAlexW2889122693

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.